CONFIDENTIAL TREATMENT
                                                              PREVIOUSLY GRANTED

                       SELLER TECHNOLOGY LICENSE AGREEMENT

     THIS AGREEMENT,  made and entered into this 31st day of July,  1995, by and
between ALBEMARLE  CORPORATION,  a Virginia  corporation having an office at 451
Florida Street,  Baton Rouge,  Louisiana 70801 (hereinafter  "ALBEMARLE"),  MEMC
ELECTRONIC  MATERIALS,  INC., a Delaware corporation having offices at 501 Pearl
Drive (City of O'Fallon), P. O. Box 8, St. Peters,  Missouri, 63376 (hereinafter
"MEMC"), and MEMC PASADENA,  INC., a Delaware corporation having offices at 3000
N. South Street, Pasadena, Texas, 77503 (hereinafter "MEMC PASADENA"):

                                   WITNESSETH

     WHEREAS,  ALBEMARLE has entered into an Asset Purchase Agreement dated July
31, 1995 with MEMC;

     WHEREAS,  the  Asset  Purchase  Agreement  provides  in  Section  3.1  that
ALBEMARLE  shall license  certain  technology and patent rights  relating to the
manufacture of polysilicon and sodium aluminum hydride;

     NOW,  THEREFORE,  for and in  consideration  of the  mutual  covenants  and
agreements hereinafter set forth, the parties agree as follows:

                             ARTICLE 1 - DEFINITIONS

     1.01 "Polysilicon  Patent Rights" shall mean the patents listed in Schedule
PAT-3 attached hereto and made a part hereof,  including all  continuations  and
continuation-in-part  patents,  divisionals,  reissues  and  reexamined  patents
derived from those listed.

     1.02 "Polysilicon Manufacturing Technology" shall mean all processes, trade
secrets,  inventions,   discoveries,   improvements,   know-how,  manufacturing,
engineering,  research, development, and testing information and other technical
information,  whether or not patentable,  developed,  used, currently in use, or
currently  planned for use by ALBEMARLE for or in connection with  manufacturing
polysilicon from silane.  Polysilicon Manufacturing Technology shall not include
information   received  by  ALBEMARLE  from  third  parties  under  the  secrecy
agreements  which are  identified  on  Schedule  I-A unless  authorized  by such
agreements or such agreements are assigned to MEMC.

     1.03 "Sodium  Aluminum  Hydride  Manufacturing  Technology"  shall mean all
processes, trade secrets, inventions, discoveries,  improvements,  know-how, and
manufacturing engineering,  research,  development,  and testing information and
other  technical  information,  whether  or  not  patentable,  developed,  used,
currently  in use, or currently  planned for use by  ALBEMARLE in  manufacturing
sodium  aluminum  hydride.  The Sodium  Aluminum  Hydride  Technology  shall not
include  information  received by ALBEMARLE from third parties under the secrecy
agreements  which are  identified  on  Schedule  I-A unless  authorized  by such
agreements or such agreements are assigned to MEMC.

     1.04 "Sodium  Aluminum Hydride Patent Rights" shall mean the patents listed
in  Schedule  PAT-2  attached  hereto  and  made a part  hereof,  including  all
continuations  and  continuation-in-part  patents,  divisionals,   reissues  and
reexamined patents derived from those listed.

     1.05 "Licensed  Product" shall mean Polysilicon which embodies,  is made by
or with the use of, or is used in accordance  with, an invention  defined by one
or more claims of the Polysilicon Patent Rights or is made using the Polysilicon
Manufacturing Technology.

     1.06  "Affiliate"  shall  have the same  meaning  as set forth in the Asset
Purchase Agreement.

     1.07  "Polysilicon  Plant"  shall  mean the  polysilicon  plant  located in
Pasadena,  Texas  and  transferred  by  ALBEMARLE  to MEMC on the  Closing  Date
including any  expansions or increases in the capacity  thereof  however made or
any polysilicon plant which replaces such polysilicon plant.

     1.08  "Net  Present  Value"  of a royalty  payment  which is due  Albemarle
pursuant to Section 2.04(a) shall be defined by the following formula:

          Net Present Value = R +  ([CONFIDENTIAL  MATERIAL HAS BEEN DELETED AND
          FILED SEPARATELY WITH SEC])n

where R is the amount of the  royalty  payment  for which the  determination  is
being made; n is an integer  denoting the number of months  following with Start
Date  to  the  end of  the  month  in  which  the  royalty  is  paid.  By way of
illustration, if a royalty is paid August 13, 1996, and the Start Date is August
31, 1995, the value of n is 12.

     1.09  "Polysilicon"  shall  collectively  mean polysilicon  which meets the
specifications  required  for  the  preparation  of  semiconductor  silicon  and
polysilicon  which meets the  specifications  required  for the  preparation  of
semiconductor   silicon  and  which,   in   addition,   has  been   upgraded  by
dehydrogenation. "Polysilicon" shall not include polysilicon which is unsuitable
for the manufacture of semiconductor grade silicon wafers.

     1.10  "Closing  Date" shall have the same meaning as set forth in the Asset
Purchase Agreement.

     1.11 "Deemed  Quantity" shall have the meaning set forth in Section 2.03(a)
of this Agreement.

     1.12 "Silane  Manufacturing  Technology" shall have the same meaning as set
forth in the Technology Purchase Agreement.

     1.13 "Silane Patent Rights" shall have the same meaning as set forth in the
Technology Purchase Agreement.

     1.14 "Silicon Tetrafluoride  Manufacturing  Technology" shall have the same
meaning as set forth in the Technology Purchase Agreement.

     1.15  "Security  Agreement"  shall  have the same  meaning  as in the Asset
Purchase Agreement.

     1.16  "Event of  Default"  shall have the same  meaning as in the  Security
Agreement.

     1.17  "Deemed  Royalty  Value" shall mean  [CONFIDENTIAL  MATERIAL HAS BEEN
DELETED AND FILED  SEPARATELY  WITH SEC]  multiplied by a fraction (X/Y) wherein
the  numerator  "X" is the  Implicit  Price  Deflator  index for Gross  Domestic
Product  published  in the  Survey  of  Current  Business  (U.S.  Department  of
Commerce, Economics and Statistics Administration,  Bureau of Economic Analysis)
at Table  7.13 as  published  on the Start Date and the  denominator  "Y" is the
Implicit Price Deflator (as defined above) for July 31, 1995.

     1.18 "Start Date" is the first to occur of the following dates; a) the date
on which funds are first appropriated by MEMC or MEMC Pasadena for any expansion
or  other  capacity  modification  of the  Polysilicon  Plant,  or b)  the  date
royalties first become due pursuant to subpart (a) of Section 2.04.

                       ARTICLE 2 - GRANTS AND COMPENSATION

     2.01  Subject  to the terms  and  conditions  set forth in this  Agreement,
ALBEMARLE   grants  to  MEMC  and  MEMC   accepts,   a   perpetual,   worldwide,
royalty-bearing as set forth in Sections 2.04, 2.05 and 2.07, exclusive (even as
against ALBEMARLE),  and irrevocable right and license,  which right and license
MEMC  may  extend  to its  Affiliates,  to  use  the  Polysilicon  Manufacturing
Technology  and to make,  have made,  use and sell the subject matter claimed in
the Polysilicon Patent Rights for any purpose,  including the right to assign to
and  sublicense  others.  Subject to the terms and  conditions set forth in this
Agreement,  MEMC hereby  grants to MEMC PASADENA and MEMC  PASADENA  accepts,  a
royalty-free  and  irrevocable  right and license,  which right and license MEMC
PASADENA may extend to its Affiliates,  under the Polysilicon  Patent Rights and
the  Polysilicon  Manufacturing  Technology  to make,  have  made,  use and sell
Licensed Product at the Polysilicon  Plant. If an Event of Default occurs and is
continuing,  ALBEMARLE shall have the right to terminate all rights and licenses
under this Section 2.01 upon written  notice to MEMC and MEMC  Pasadena  and, in
such event, MEMC and MEMC Pasadena shall cease any further use of the technology
and patent rights licensed under this Section 2.01.

     2.02  Subject  to the terms  and  conditions  set forth in this  Agreement,
ALBEMARLE   grants  to  MEMC  and  MEMC   accepts,   a   perpetual,   worldwide,
royalty-bearing as set forth in Sections 2.04, 2.05 and 2.07, exclusive (even as
against ALBEMARLE),  and irrevocable right and license,  which right and license
MEMC  may  extend  to  its  Affiliates,   under  the  Sodium  Aluminum   Hydride
Manufacturing   Technology  and  the  Sodium  Aluminum  Hydride  Patent  Rights,
including the right to sublicense  others,  to make,  have made,  and use sodium
aluminum hydride to make, have made, use and sell silane and to make, have made,
use and sell  sodium  aluminum  fluoride.  No right or license is granted to use
sodium  aluminum  hydride  manufactured  under  license  for any other  purpose.
Subject to the terms and conditions set forth in this Agreement,  MEMC grants to
MEMC PASADENA and MEMC PASADENA  accepts a royalty-free,  irrevocable  right and
license,  which right and license MEMC  PASADENA  may extend to its  Affiliates,
under the  Sodium  Aluminum  Hydride  Manufacturing  Technology  and the  Sodium
Aluminum  Hydride Patent  Rights,  to make,  have made, and use sodium  aluminum
hydride to make,  have made, use and sell silane and to make, have made, use and
sell sodium aluminum  fluoride at the Polysilicon  Plant. If an Event of Default
occurs and is continuing, ALBEMARLE shall have the right to terminate all rights
and  licenses  under  this  Section  2.02 upon  written  notice to MEMC and MEMC
Pasadena and, in such event,  MEMC and MEMC Pasadena shall cease any further use
of the technology and patent rights licensed under this Section 2.02.

     2.03 MEMC agrees to promptly provide ALBEMARLE with notice in writing prior
to or upon taking any of the following actions:

     (a)  making more than  [CONFIDENTIAL  MATERIAL  HAS BEEN  DELETED AND FILED
          SEPARATELY  WITH SEC] metric tons of  Polysilicon  in the  Polysilicon
          Plant in any calendar year ("Deemed  Quantity") (notice being required
          in each such year when production exceeds the Deemed Quantity, or

     (b)  granting  any  right to a third  party to use the  Polysilicon  Patent
          Rights and/or  Polysilicon  Manufacturing  Technology  to  manufacture
          polysilicon, or

     (c)  increasing  the  capacity of the  Polysilicon  Plant beyond the Deemed
          Quantity by expansion, debottlenecking or other means, or

     (d)  building  a plant for the  manufacture  of  polysilicon  for a purpose
          other than to replace the capacity of the polysilicon plant located in
          Pasadena,  Texas and  transferred  by ALBEMARLE to MEMC on the Closing
          Date.

     2.04 In partial  consideration  for the rights  granted  herein,  Albemarle
shall  receive  a royalty  for sales of  Licensed  Product  manufactured  at the
Polysilicon Plant during the fifteen (15) year period immediately  following the
Closing Date as set forth below:

               (a) for each  kilogram of Licensed  Product sold by MEMC PASADENA
          to its Affiliates and to third parties in a calendar year in excess of
          [CONFIDENTIAL MATERIAL HAS BEEN DELETED AND FILED SEPARATELY WITH SEC]
          metric  tons but not in  excess  of  [CONFIDENTIAL  MATERIAL  HAS BEEN
          DELETED AND FILED  SEPARATELY  WITH SEC] metric tons,  Albemarle shall
          receive a royalty of [CONFIDENTIAL MATERIAL HAS BEEN DELETED AND FILED
          SEPARATELY WITH SEC], and

               (b) for each kilogram of Licensed Product sold in a calendar year
          in  excess  of  [CONFIDENTIAL  MATERIAL  HAS BEEN  DELETED  AND  FILED
          SEPARATELY WITH SEC] metric tons, Albemarle shall receive a royalty to
          be  determined  by  MEMC  and  Albemarle  pursuant  to  a  good  faith
          negotiation as described in Section 2.06.

The  obligation  to pay  royalties to Albemarle  pursuant to subpart (a) of this
Section 2.04 shall terminate fifteen years from the Closing Date or when the Net
Present Value of all royalties paid to Albemarle pursuant to subpart (a) of this
Section  2.04 is equal to the Deemed  Royalty  Value,  whichever is the first to
occur.  The obligation to pay royalties to Albemarle  pursuant to subpart (b) of
this Section  2.04 shall  terminate  fifteen  years from the Closing  Date.  All
royalties due Albemarle pursuant to this Section 2.04 shall be paid to Albemarle
within thirty (30) days following the close of the calendar quarter in which the
sale of the royalty-bearing product occurred.

     2.05 If at any one or more  times  during  the  fifteen  (15)  year  period
immediately  following the Closing Date, MEMC, MEMC PASADENA or any Affiliate of
MEMC or MEMC PASADENA  manufactures  Licensed  Product at a plant other than the
Polysilicon Plant, Albemarle, in addition to any royalties which may be required
by Section 2.04 for Licensed  Product  manufactured  at the  Polysilicon  Plant,
shall  receive a royalty  for the making,  using or selling of Licensed  Product
manufactured  at each  such new  plant  within  the  fifteen  (15)  year  period
immediately following the Closing Date, the royalty to be determined by MEMC and
Albemarle pursuant to a good faith negotiation as described in Section 2.07.

     2.06 In  conducting  negotiations  required  by Section  2.04(b) or Section
2.05, the parties shall use in their consideration the premise that ALBEMARLE is
50%  owner  of  the  Polysilicon   Patent  Rights,   Polysilicon   Manufacturing
Technology,  Sodium Aluminum  Hydride Patent Rights and Sodium Aluminum  Hydride
Manufacturing  Technology  and  further  that  the  Polysilicon  Patent  Rights,
Polysilicon  Manufacturing  Technology,  Sodium Aluminum  Hydride Patent Rights,
Sodium Aluminum Hydride Manufacturing  Technology,  Silane Patent Rights, Silane
Manufacturing Technology and Silicon Tetrafluoride Manufacturing Technology were
valued,  as of the Closing  Date,  [CONFIDENTIAL  MATERIAL  HAS BEEN DELETED AND
FILED  SEPARATELY WITH SEC].  MEMC and ALBEMARLE agree to use such  contemplated
value as a basis for their negotiations, provided, however, that if ALBEMARLE or
MEMC can  demonstrate  in good  faith  that such  contemplated  value is not the
actual value at the time of such negotiations,  then that party may address that
issue as part of the negotiations.  Failing agreement upon a mutually acceptable
royalty  to be paid to  ALBEMARLE  in the  event  of the  occurrence  of acts as
described in 2.04(b) or 2.05, then MEMC and ALBEMARLE shall submit the matter to
arbitration in accordance with the provisions of Section 8.05.

     2.07 If at any one or more  times  MEMC or MEMC  PASADENA  (or any of their
Affiliate(s),  successor(s),  licensee(s)  or  assign(s))  transfers  any of the
Polysilicon Patent Rights, the Polysilicon Manufacturing Technology,  the Sodium
Aluminum Hydride Patent Rights and/or the Sodium Aluminum Hydride  Manufacturing
Technology  by way of license,  sale or  otherwise,  to any third  party  within
fifteen years of the Closing Date,  then ALBEMARLE shall be paid by MEMC or MEMC
PASADENA for each such  transaction the cash equivalent of one-half of any value
(whether  such  value is in terms of cash  compensation,  supply  or  barter  of
product or technology,  cross  licensing of technology or any other value of any
kind) received by or to be received by MEMC or MEMC PASADENA (or either of their
Affiliate(s),  successor(s),  licensee(s) or assign(s))  within fifteen years of
the Closing  Date for the  transfer or the  licensing  of such patent  rights or
technology, such one-half share (in its cash equivalent) to be paid to ALBEMARLE
within  thirty (30) days from the receipt by MEMC or MEMC PASADENA (or either of
their Affiliate(s), successor(s), licensee(s) or assign(s)) of such cash or such
other  value  (whether  such value is in terms of supply or barter of product or
technology,  cross  licensing  of  technology  or any other  value of any kind).
Notwithstanding  the  foregoing,  in the event such a third party pays value for
such a transfer of rights,  some of which is paid within  fifteen years and some
of which is paid more than fifteen years after the Closing  Date,  ALBEMARLE and
MEMC shall, upon the request of either party,  negotiate in good faith such that
ALBEMARLE and MEMC shall receive a fair and equitable portion of the value paid,
taking  into  account  the  extent to which the  timing of the value paid by the
third party  corresponds to the timing of the value received by the third party.
In conducting such  negotiations,  the parties shall use in their  consideration
the  premise  that  ALBEMARLE  is 50% owner of the  Polysilicon  Patent  Rights,
Polysilicon Manufacturing Technology, Sodium Aluminum Hydride Patent Rights, and
Sodium Aluminum Hydride Manufacturing  Technology and that it is contemplated by
ALBEMARLE and MEMC that the Polysilicon Patent Rights, Polysilicon Manufacturing
Technology,  Sodium  Aluminum  Hydride Patent Rights,  Sodium  Aluminum  Hydride
Manufacturing Technology,  Silane Patent Rights, Silane Manufacturing Technology
and  Silicon  Tetrafluoride  Manufacturing  Technology  were  valued,  as of the
Closing Date,  [CONFIDENTIAL MATERIAL HAS BEEN DELETED AND FILED SEPARATELY WITH
SEC].  MEMC and ALBEMARLE  agree to use such  contemplated  value as a basis for
their negotiations, provided, however, that if ALBEMARLE or MEMC can demonstrate
in good faith that such  contemplated  value is not the actual value at the time
of such  negotiations,  then that  party may  address  that issue as part of the
negotiations. Failing agreement upon a mutually acceptable portion to be paid to
ALBEMARLE,  then MEMC and ALBEMARLE  shall submit the matter to  arbitration  in
accordance with the provisions of Section 8.05.

                       ARTICLE 3 - MAINTENANCE OF PATENTS

     3.01 MEMC shall pay all  taxes,  fees or other  expenditures,  and take any
other  measures  that  MEMC  believes  necessary  (in its  sole  discretion)  to
prosecute, issue or maintain the Polysilicon Patent Rights.

     3.02  ALBEMARLE,  in its  discretion,  shall pay all  taxes,  fees or other
expenditures  and take any  other  measures  necessary  to  prosecute,  issue or
maintain the Sodium Aluminum Hydride Patent Rights.

     3.03 If ALBEMARLE,  in its discretion,  determines it will not proceed with
any act or take any measure  required  under 3.02,  to obtain or maintain any of
the licensed patent rights relating to sodium aluminum hydride,  ALBEMARLE shall
provide  timely  notice of such  decision  to MEMC and shall,  at the request of
MEMC,  assign to MEMC the sodium  aluminum  hydride patent  involved in time for
MEMC to undertake any such act or measure.

                           ARTICLE 4 - CONFIDENTIALITY

     4.01 ALBEMARLE shall refrain from disclosing the Polysilicon  Manufacturing
Technology.

     4.02  Notwithstanding the foregoing,  ALBEMARLE is not under any obligation
of confidentiality with respect to any technical information that is part of the
Polysilicon Manufacturing Technology that:

     (a)  at the time of  disclosure  is  generally  available  to the public or
          thereafter becomes generally available to the public by publication or
          otherwise not arising through an act or omission of ALBEMARLE, or

     (b)  is independently made available to ALBEMARLE as a matter of right by a
          third party, or

     (c)  is required by a court or government agency to be disclosed,  provided
          that  ALBEMARLE  gives MEMC at least  thirty (30) days' notice of such
          requirement  so that  MEMC  will have an  opportunity  to oppose  such
          requirement.

For the purpose of the provisions of this paragraph 4.02, technical  information
within  the  Polysilicon  Manufacturing  Technology  shall  not be  deemed to be
generally available to the public or independently  received by ALBEMARLE merely
because  it may be  embraced  by a more  general  disclosure,  or  derived  from
combinations of disclosures,  generally available to the public or independently
made available to ALBEMARLE.

     4.03 MEMC  shall  refrain  from  disclosing  the  Sodium  Aluminum  Hydride
Manufacturing Technology except pursuant to a confidentiality  agreement no less
restrictive than the terms of this Agreement.

     4.04  Notwithstanding  the  foregoing,  MEMC is not under any obligation of
confidentiality  with respect to any technical  information  that is part of the
Sodium Aluminum Hydride Manufacturing Technology that:

     (a)  At the time of  disclosure  is  generally  available  to the public or
          thereafter becomes generally available to the public by publication or
          otherwise not arising through an act or omission of MEMC, or

     (b)  MEMC  can  show  was in  its  possession  prior  to  the  time  of the
          disclosure  hereunder and was not acquired directly or indirectly from
          ALBEMARLE, or

     (c)  is  independently  made  available  to MEMC as a matter  of right by a
          third party, or

     (d)  is required by a court or government agency to be disclosed,  provided
          that MEMC gives  ALBEMARLE  at least  thirty  (30) days notice of such
          requirement  so that ALBEMARLE will have an opportunity to oppose such
          requirement.

For the purpose of the provision of this paragraph 4.04,  technical  information
within the Sodium Aluminum Hydride Manufacturing  Technology shall not be deemed
to be  generally  available  to the public or in the  possession  of MEMC merely
because  it may be  embraced  by a more  general  disclosure,  or  derived  from
combinations  of  disclosures,  generally  available  to  the  public  or in the
possession of MEMC.

                             ARTICLE 5 - TERMINATION

     This Agreement shall terminate upon the expiration of the last to expire of
all patents listed in Schedules PAT-2 and PAT-3 attached hereto, except that the
licenses of Polysilicon  Manufacturing  Technology and Sodium  Aluminum  Hydride
Manufacturing   Technology   granted  in  Article  2  and  the   confidentiality
obligations of Article 4 shall survive such termination.

                          ARTICLE 6 - OPTION TO ASSIGN

     At any time,  for and in  consideration  of the sum of One Dollar  ($1.00),
upon notice by MEMC,  ALBEMARLE  agrees to sell,  assign,  transfer and set over
unto MEMC the  entire  right,  title and  interest  of  ALBEMARLE  in and to the
Polysilicon Manufacturing Technology and the Polysilicon Patent Rights. Any such
assignment  shall have no effect on the  obligations  of Article 2 (licenses and
royalty payments) or the obligations of the Security  Agreement.  If an Event of
Default  occurs  and is  continuing,  ALBEMARLE  shall have the right to request
reassignment  to  ALBEMARLE  of all  rights  assigned  under this  Section,  and
promptly following such request,  MEMC and MEMC Pasadena shall cease any further
use of the  technology  and patent rights  assigned  under this section and will
also reassign all such patent and  technology  rights to ALBEMARLE and will also
execute such  assignment  documents in  recordable  form as are necessary in the
opinion of ALBEMARLE to record the reassignment.

                               ARTICLE 7 - NOTICES

     Any  notice  provided  for  herein  to be  given  in  writing  shall  be by
registered or certified mail addressed or by facsimile to the respective parties
at their addresses set forth below or at such other address or addresses as such
parties may from time to time designate in written notice to the other:

         ALBEMARLE:
                                    Albemarle Corporation
                                    451 Florida Street
                                    Baton Rouge, Louisiana 70801

                                    Attention:  Law Department

         MEMC:
                                    MEMC Electronic Materials, Inc.
                                    501 Pearl Drive (City of O'Fallon)
                                    Post Office Box 8
                                    St. Peters, Missouri 63376
                                    Phone:  (314) 279-5000
                                    Facsimile:  (314) 279-5158

                                    Attention: Vice President, Technology

                               ARTICLE 8 - GENERAL

     8.01 This  Agreement,  the  Technology  Purchase  Agreement,  the  Security
Agreement and the Asset  Purchase  Agreement set forth the entire  agreement and
understanding  of the parties  with  respect to the subject  matter  hereof.  No
representation,  promise,  inducement or statement of intention  relating to the
subject matter  contemplated  by this Agreement has been made by any party which
is not set forth in this Agreement or in the documents referred to herein.

     8.02 This  Agreement  may be  amended,  superseded  or  canceled  only by a
writing  specifically  referring  to  this  Agreement  and  signed  by the  duly
authorized representative of both parties.

     8.03 This  Agreement  shall be  governed  by the law of the State of Texas,
excluding the conflicts of laws provisions thereof to the extent such laws would
dictate application of the laws of another jurisdiction.

     8.04 The licenses  granted  pursuant to  paragraph  2.01 may be assigned or
transferred in any manner by MEMC without the consent of ALBEMARLE provided that
ALBEMARLE is notified of the  assignment  and the assignee  agrees to assume the
obligations  set forth in  paragraphs  2.03,  2.04,  2.05,  2.06 and  2.07.  The
licenses  granted pursuant to paragraph 2.02 may be assigned to the successor in
interest of MEMC in the business to which such licenses  pertain.  ALBEMARLE can
assign any or all of its rights  under this  Agreement  at any time  without the
consent of MEMC.

     8.05 For any matter which is designated in this  Agreement as being subject
to arbitration,  the parties shall, unless agreed otherwise, submit any disputes
for  settlement  and   determination  by  arbitration   under  the  then-current
Commercial Arbitration rules of the American Arbitration Association.  The panel
for such arbitration shall consist of three (3) arbitrators,  each of whom shall
be attorneys  with at least ten (10) years of  experience  before the Bar of any
state in commercial  matters.  The arbitration shall be held in Houston,  Texas.
The costs and expenses of the  arbitration  shall be shared as determined by the
arbitration panel. Discovery will be allowed both parties before the arbitration
hearing in accord  with the  Federal  Rules of Civil  Procedure  and the hearing
shall be conducted  consistent with the Federal Rules of Evidence.  The decision
and award of the panel shall be in writing  with  reasons  provided and shall be
final and  binding.  The award so  rendered  may be entered in any court  having
jurisdiction thereof confirmation and enforcement.

     8.06 Each party  agrees to execute or cause to be  executed  any  documents
reasonably  required to grant or  otherwise  perfect the rights  purported to be
granted herein, provided,  however, that neither party shall be required by this
section to enter into any  transaction  with a third  party.  Any  out-of-pocket
expenses incurred under this Section shall be reimbursed by the party requesting
such services.

     IN WITNESS  WHEREOF,  the parties by their duly authorized  representatives
have executed this Agreement on the date first written above.

                                  ALBEMARLE CORPORATION

                                  By:  /s/ Thomas Avant
                                     -------------------------------------------
                                  Title:  Senior Vice President, Finance


                                  MEMC ELECTRONIC MATERIALS, INC.

                                  By:  /s/ John DeLuca
                                     -------------------------------------------
                                  Title: Corporate Vice President


                                  MEMC PASADENA, INC.

                                  By:  /s/ John DeLuca
                                     -------------------------------------------
                                  Title: President




                                 SCHEDULE PAT-3
                            POLYSILICON PATENT RIGHTS
                                                                         

CASE              COUNTRY     STATUS   APPN.            FILING                  PATENT     ISSUE
NUMBER                                 NUMBER           DATE                    NUMBER     DATE
- ---------------------------------------------------------------------------------------------------

EM-5522-A         USA         ISSUED    105.867         10/08/87                4.857.173  08/15/89
EM-5461-B         USA         ISSUED    059.562         06/08/87                4.806.317  02/21/89
EM-5461-D         USA         ISSUED    221.657         07/20/88                5.059.410  10/22/91
EM-5461-F         USA         ISSUED    426.846         10/26/89                5.202.099  04/13/93
EM-5461-H         USA         ISSUED    892.698         05/28/92                5.205.998  04/27/93
EM-5461           CANAD       GRANTED   514.570         07/24/86                1.323.339  10/19/93
EM-5461           JAPAN       GRANTED   181827/86       08/01/86                1859201    07/27/94
EM-5266           USA         ISSUED    796.190         11/08/85                4.691.866  09/08/87
EM-5266           JAPAN       GRANTED   162208/87       06/29/87                1794186    10/14/93
EM-5512-A         USA         ISSUED    004.116         01/16/87                4.820.587  04/11/89
EM-5512-B         USA         ISSUED    114.453         10/28/87                7.784.840  11/15/88
EM-5512-C         USA         ISSUED    290.584         12/27/88                4.883.687  11/28/89
EM-5512+          CANAD       GRANTED   544.103         98/10/87                1.294.755  01/28/92
EM-5512+          JAPAN       PUBLISHED 208030/87       08/21/87
EM-5512+          EPO         GRANTED   87-307464.5     08/24/87                0 258 027  08/19/92
EM-5512+          TAIWN       GRANTED   76-105096       08/29/87                NI 32354   09/01/89
EM-5512+          BELGM       GRANTED   87-307464-5     08/24/87                0258027    08/19/92
EM-5512+          FRANC       GRANTED   87-307464-5     08/24/87                0258027    08/19/92
EM-5512+          GERWE       GRANTED   87-307464-5     08/24/87                P3781223.8 08/19/92
EM-5512+          ITALY       GRANTED   87-307464-5     08/24/87                0258027    08/19/92
EM-5512+          UNIKN       GRANTED   87-307464-5     08/24/87                0258027    08/19/92
EM-5543           USA         ISSUED    088.145         08/21/87                4.748.052  05/31/88
EM-5543-A         USA         ISSUED    165.187         03/07/88                4.868.013  09/19/89
EM-5543           CANAD       GRANTED   575.224         08/19/88                1.303.816  06/23/92
EM-5543           JAPAN       PUBLISHED 204839/88       08/19/88
EM-5543           KORSO       PUBLISHED 10576/1988      08/20/88
EM-5543           TAIWN       GRANTED   77105585        08/12/88                35307      03/26/90
EM-5543           EPO         GRANTED   88-113076.9     08/11/88                0303973    01/27/93
EM-5543           BELGM       GRANTED   88-113076.9     08/11/88                0303973    01/27/93
EM-5543           FRANC       GRANTED   88-113076.9     08/11/88                0303973    01/27/93
EM-5543           GERWE       GRANTED   88-113076.9     08/11/88                P3877857.2 01/27/93
EM-5543           ITALY       GRANTED   88-113076.9     08/11/88                0303973    01/27/93
EM-5543           UNIKN       GRANTED   88-113076.9     08/11/88                0303973    01/27/93
EM-5704           USA         ISSUED    126.203         11/27/87                4.789.596  12/06/88
EM-5704-B         USA         ISSUED    212.286         06/27/88                4.952.425  08/28/90
EM-5704-C         USA         ISSUED    212.231         06/27/88                4.851.297  07/25/89
EM-5704           CANAD       GRANTED   584.183         11/25/88                1.309.308  10/27/92
EM-5704           JAPAN       PUBLISHED 296409/88       11/25/88
EM-5704           KORSO       PUBLISHED 88-15662        11/26/88
EM-5704           TAIWN       GRANTED   77108649        12/12/88                N147709    09/26/91
EM-5704           EPO         GRANTED   88-119601.8     11/24/88                0318008    06/22/94
EM-5704           EPO         PUBLISHED 92-105047.2     03/24/92
EM-5704           BELGM       GRANTED   88-119601.8     11/24/88                0318008    06/22/94
EM-5704           FRANC       GRANTED   88-119601.8     11/24/88                0318008    06/22/94
EM-5704           GERWE       GRANTED   88-119601.8     11/24/88                P38503573  06/22/94
EM-5704           ITALY       GRANTED   88-119601.8     11/24/88                0318008    06/22/94
EM-5704           UNIKN       GRANTED   88-119601.8     11/24/88                0318008    06/22/94
EM-5705-A         USA         ISSUED    791.882         11/13/91                5,242.671  09/07/93
EM-5705-B         USA         ISSUED    053.527         04/26/93                5.326.547  07/05/94
EM-5705           CANAD       PENDING   612.125         09/20/89
EM-5705           JAPAN       PUBLISHED 262279/89       10/09/89
EM-5705           KORSO       GRANTED   14577/1989      10/11/89                69463      01/05/94
EM-5705           EPO         GRANTED   89-1179624      09/28/89                0363742    06/09/93
EM-5705           FRANC       GRANTED   89-1179624      09/28/89                0363742    06/09/93
EM-5705           GERWE       GRANTED   89-117962.4     09/28/89                P68907001. 06/09/93
EM-5705           ITALY       GRANTED   89-117962.4     09/28/89                0363742    06/09/93
EM-5705           UNIKN       GRANTED   89-117962.4     09/28/89                0363742    06/09/93
EM-5712           USA         ISSUED    092,638         09/03/87                4,871,524  10/03/89
EM-5712           CANAD       GRANTED   574,472         08/11/88                1,289,454  09/24/91
EM-5712           JAPAN       PUBLISHED 218691/88       09/02/88
EM-5712           KORSO       PUBLISHED 11398/1988      09/03/88
EM-5712           TAIWN       GRANTED   77105745        08/19/88                NI43359    04/09/91
EM-5712           EPO         GRANTED   88-113730.1     08/23/88                0305867    06/26/91
EM-5712           BELGM       GRANTED   88-113730.1     08/23/88                0305867    06/26/91
EM-5712           FRANC       GRANTED   88-113730.1     08/23/88                0305867    06/26/91
EM-5712           GERWE       GRANTED   88-113730.1     08/23/88                P3863411.2 06/26/91
EM-5712           ITALY       GRANTED   88-113730.1     08/23/88                0305867    06/26/91
EM-5712           UNIKN       GRANTED   88-113730.1     08/23/88                0305867    06/26/91
EM-6074           USA         ISSUED    457,310         12/26/89                4,970,891  11/20/90
EM-6512           USA         ISSUED    865,972         04/09/92                5,260,538  11/09/93
EM-6535           USA         ISSUED    963,814         10/20/92                5,322,670  06/21/94
EM-6541           USA         ISSUED    963,661         10/20/92                5,405,658  04/11/95
EM-6541           JAPAN       PENDING   US93/09545      10/06/93
EM-6541           CANAD       PENDING   US93/09545      10/06/93
EM-6553           USA         ISSUED    957,319         10/06/92                5,358,603  10/25/94
EM-6536-B         USA         ISSUED    179,410         01/10/94                5,419,462  05/30/95
EM-6536           JAPAN       PENDING   246135/93       09/07/93
EM-6541-A         USA         PENDING   401,371         03/09/95




                                  Schedule 1-A

Name                                        Type

Ahmet Baysar                        Secrecy - Production high purity silicon in
                                    fluidized bed using microwaves

M. P. Dudukovic                     Consulting/Secrecy - Field of chemical
                                    engineering; discussions re fluid bed model
                                    for silane decomposition

M. P. Dudukovic                     Consulting - Multiphase reactors

M. P. Dudukovic                     Consulting - Silicon Crystal Pulling

M. P. Dudukovic                     Consulting/Secrecy - Field of chemical
                                    engineering; discussions re fluid bed model
                                    for silane decomposition

Donald C. Freshwater                Consulting/Secrecy - manufacturing poly-
                                    silicon

L. J. Giling                        Consulting - semiconductor materials

L. J. Giling                        Consulting - semiconductor materials

L. J. Giling                        Consulting - one year extension re MOCVD
                                    agreement

L. J. Giling                        Consulting - semiconductor materials and
                                    MOCVD

L. J. Giling                        Consulting - metal organic chemical vapor
                                    deposition (MOCVD) of III-V compounds

James L. Kuester                    Secrecy - Production high purity silicon in
                                    fluidized bed using microwaves

F. F. Lange                         Consulting - polysilicon and silicon
                                    carbide ceramics

David C. Look                       Consulting - semiconductor materials

Robert C. Wright                    Secrecy - covering consultations re Ethyl's
                                    polysilicon project

Frederick A. Zenz                   Consulting - Polysilicon manufacturing





                                 SCHEDULE PAT-2

                      SODIUM ALUMINUM HYDRIDE PATENT RIGHTS

                                                                          

CASE              COUNTRY     STATUS   APPN.           FILING                   PATENT      ISSUE
NUMBER                                 NUMBER          DATE                     NUMBER      DATE
- ----------------------------------------------------------------------------------------------------

EM-5065           USA         ISSUED   496.474         05/20/83                 4.456.584   06/26/84
EM-5065           CANAD       GRANTED  452.120         04/16/84                 1.203.673   04/29/86
EM-5065           TAIWN       GRANTED  7.311.538       04/18/84                 NI-24629    07/25/86
EM-5065           EPO         GRANTED  84-105704.5     05/18/84                 0129079     11/11/87
EM-5065           FRANC       GRANTED  84-105704.5     05/18/84                 0129079     11/11/87
EM-5065           GERWE       GRANTED  84-105704.5     05/18/84                 P3467334.2  11/11/87
EM-5065           ITALY       GRANTED  84-105704.5     05/18/84                 0129079     11/11/87
EM-5065           HOLLN       GRANTED  84-105704.5     05/18/84                 0129079     11/11/87
EM-5065           UNIKN       GRANTED  84-105704.5     05/18/84                 0129079     11/11/87
EM-5129           USA         ISSUED   450.032         12/15/82                 4.528.176   07/09/85
EM-5129+          CANAD       GRANTED  443.198         12/13/83                 1.200.365   02/11/86
EM-5129+          TAIWN       GRANTED  73-10012        01/05/84                 NI-24621    07/25/86
EM-5129+          EPO         GRANTED  83-3076425      12/15/83                 0112175     03/29/89
EM-5129+          FRANC       GRANTED  83-3076425      12/15/83                 0112175     03/29/89
EM-5129+          GERWE       GRANTED  83-3076425      12/15/83                 P3379500.2  03/29/89
EM-5129+          ITALY       GRANTED  83-3076425      12/15/83                 0112175     03/29/89
EM-5129+          HOLLN       GRANTED  83-3076425      12/15/83                 0112175     03/29/89
EM-5129+          UNIKN       GRANTED  83-3076425      12/15/83                 0112175     03/29/89
EM-5159           USA         ISSUED   557.206         12/02/83                 4.512966    04/23/85